The Incidence of Metabolic Syndrome in Women with Impaired Reproductive Function According to Astana, Kazakhstan

Authors: A. T. Nakysh, A. S. Idrisov, S. A. Baidurin

Abstract:

This work presents the results of a study the incidence of metabolic syndrome (MetS) in women with impaired reproductive function (IRF) according to the data of Astana, Kazakhstan. The anthropometric, biochemical and instrumental studies were conducted among 515 women, of which 53 patients with MetS according to IDF criteria, 2006, were selected. The frequency of occurrence of the IRF, due to MetS is 10.3% of cases according to the data of Astana. In women of childbearing age with IRF and the MetS, blood pressure (BP), indicators of carbohydrate and lipid metabolism were significantly higher and the level of high density lipoprotein (HDL) significantly lower compared to the same in women with the IRF without MetS. The hyperandrogenism, the hyperestrogenemia, the hyperprolactinemia and the hypoprogesteronemia were found in the patients with MetS and IRF, indicating the impact of MetS on the development of the polycystic ovary syndrome in 28% of cases and hyperplastic processes of the myometrium in 20% of cases.

Keywords: Dyslipidemia, insulin resistance, metabolic syndrome, reproductive disorders, obesity.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1335926

References:

[1] E. Kassi, P. Pervanidou, G. Kaltsas and G. Chrousos, "Metabolic syndrome: definitions and controversies,” BMC Medicine,9: 2011,p. 48.
[2] J.X. Wong, M. J. Davies, R.J. Norman, "Obesity increases the risk of spontaneous abortion during infertility treatment,” Obes Res., 10, 2002, р. 551–554.
[3] K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, et al., "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity,” Circulation, 120(16), 2009, pp.1640–1645.
[4] M.C. Foss-Freitas, P.M. Gomes, R.C.G. Andrade, R.C.Figueiredo, A.E. Pace, A.L. Dal Fabbro, et al., "Prevalence of the metabolic syndrome using two proposed definitions in a Japanese-Brazilians community,” Diabetology& Metabolic Syndrome,4:2012, p.38.
[5] J.D. Brunzell, A.F. Ayyobi, "Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus,” Am J Med,Dec 8 2003;115Suppl 8A:24S-28S.
[6] T. Takeda, M. Sakata, A. Isobe, A. Miyake, F. Nishimoto, Y. Ota, et al., "Relationship between metabolic syndrome and uterine leiomyoma: a case-control study,” Gynecologic and Obstetric Investigation,02/2008, 66(1), pp.14-7.